Guggenheim raised the firm’s price target on Amicus (FOLD) to $15 from $13 and keeps a Buy rating on the shares after Q3 sales came in above consensus and management increased fiscal year Galafold and Pombiliti guidance. The Amicus “story could be compelling to a range of strategic buyers in 2025,” the analyst tells investors in a post-earnings note.